Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Placenta ; 32(11): 885-92, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21893339

ABSTRACT

Syncytins are genes of retroviral origin that have been co-opted by mammalian hosts for a function in placentation. Two such genes have already been identified in simians, as well as two distinct, unrelated ones in Muridae and a fifth in the rabbit. Here we searched for similar genes in the guinea pig, which belongs to the Caviomorpha lineage within the Hystricognathi suborder of rodents and displays a placental structural organization with several characteristic features comparable to those of the human organ, including deep trophoblast invasion of maternal tissues. An in silico search for envelope (env) genes with full coding capacity identified a candidate gene that showed specific expression in the placenta, as revealed by RT-qPCR using RNAs from a large panel of tissues. This gene belongs to an endogenous retroviral element present at a single-copy in the guinea pig genome, still displaying a retroviral organization - with a degenerate gag and pol, but an intact env gene. In situ hybridization of guinea pig placenta sections demonstrated specific expression at the level of the invasive trophoblast-containing junctional zone, as observed in humans for syncytin-1 and consistent with a role in invasion of the maternal uterine tissues. The identified gene displays a conserved open reading frame in the Caviomorpha, consistent with an entry date >30 million years, and sequence analyses showed purifying selection of the gene. Conclusively, despite the absence of a demonstrated fusogenic activity, it is likely that the identified env gene - that we named syncytin-like env-Cav1 - exerts a physiological function possibly related to trophoblast invasion, in the course of caviomorph placentation.


Subject(s)
Endogenous Retroviruses/genetics , Gene Products, env/genetics , Guinea Pigs/genetics , Placenta/metabolism , Pregnancy Proteins/genetics , Amino Acid Sequence , Animals , Conserved Sequence , Female , Gene Expression , Intercellular Junctions/genetics , Intercellular Junctions/metabolism , Models, Biological , Molecular Sequence Data , Organ Specificity/genetics , Phylogeny , Pregnancy , Rodentia/genetics , Rodentia/metabolism
2.
Placenta ; 28(7): 639-49, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17116327

ABSTRACT

It is now well established that cells are exchanged between mother and fetus during gestation. It has been proposed that some of these exchanges take place in the placenta, but it has never been demonstrated. Here, we made use of EGFP (Enhanced Green Fluorescent Protein) transgenic mice to precisely visualize the juxtaposition of maternal and fetal tissues at the implantation site, as well as to describe the bi-directional cell trafficking between mother and fetus at different stages of gestation. The influence of genetic differences between mother and fetus on the cell migration was also addressed by studying various types of matings: syngeneic, allogeneic and outbred. The frequency of maternal-fetal cell exchanges within the placenta is much higher in syngeneic and allogeneic gestations than in outbred ones. Maternal cells were mainly localized in the labyrinth where they were scattered or sometimes grouped in or near blood spaces. Groups of maternal cells could also be observed in maternal blood sinuses of the spongiotrophoblast. Conversely, fetal cells were organized in rings surrounding maternal blood sinuses in the decidua at 10-12 days of gestation. After day 13, they invaded the decidua. Fetal cells could also be detected in maternal peripheral blood and organs by nested PCR and fluorescence microscopy on cryosections, respectively. This suggests a role in the establishment and maintenance of the maternal tolerance to the fetus.


Subject(s)
Cell Movement , Fetus/cytology , Maternal-Fetal Exchange , Placenta/cytology , Animals , Female , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Mice , Mice, Transgenic , Pregnancy
3.
FEBS Lett ; 510(1-2): 94-8, 2002 Jan 02.
Article in English | MEDLINE | ID: mdl-11755538

ABSTRACT

Peroxisome proliferator-activated receptor (PPAR) gamma was shown to be required for adipocyte formation both in vivo and in vitro. However, the role of PPARgamma in the initial steps of adipose cell development was not distinguished from its role in the terminal steps. We now show that PPARgamma is expressed early in embryoid bodies (EBs) derived from embryonic stem cells and in E.8.5 mouse embryos. Addition of a specific ligand for PPARgamma in developing EBs over-expressing PPARgamma did not commit stem cells towards the adipose lineage. In differentiated PPARgamma(-/-) EBs, only markers characteristic of preadipocytes were found to be expressed. PPARdelta is present in EBs but did not compensate for the lack of PPARgamma in terminal differentiation. Taken together, these results favor a critical PPARgamma-independent phase culminating in preadipocyte formation that precedes a PPARgamma-dependent phase in the development of adipose cells from pluripotent stem cells.


Subject(s)
Adipocytes/cytology , Receptors, Cytoplasmic and Nuclear/metabolism , Stem Cells/cytology , Thiazolidinediones , Transcription Factors/metabolism , Adipocytes/metabolism , Animals , Biomarkers , Cell Differentiation , Cell Lineage , Cells, Cultured , Gene Expression , HMGA2 Protein/genetics , Lipoprotein Lipase/genetics , Mice , Mice, Inbred C57BL , Receptors, Cytoplasmic and Nuclear/genetics , Rosiglitazone , Stem Cells/metabolism , Thiazoles/pharmacology , Transcription Factors/genetics , Tretinoin/metabolism , Tretinoin/pharmacology
4.
Biochem Biophys Res Commun ; 284(2): 478-84, 2001 Jun 08.
Article in English | MEDLINE | ID: mdl-11394905

ABSTRACT

Embryonic stem (ES) cells have the capacity to differentiate into various cell types in vitro. In this study, we show that retinoic acid is important for the commitment of ES cells into osteoblasts. Culturing retinoic acid treated ES cells in the presence of the osteogenic supplements ascorbic acid and beta-glycerophosphate resulted in the expression of several osteoblast marker genes, osteocalcin, alkaline phosphatase, and osteopontin. However, there was only a slight amount of mineralized matrix secretion. Addition of bone morphogenic protein-2 or compactin, a drug of the statin family of HMG-CoA reductase inhibitors, resulted in a greatly enhanced formation of bone nodules. Compactin did not modify the expression of osteogenic markers, but at the late stage of differentiation promoted an increase in BMP-2 expression. These results establish ES-cell derived osteogenesis as an effective model system to study the molecular mechanisms by which the statin compactin promotes osteoblastic differentiation and bone nodule formation.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Cell Differentiation/drug effects , Lovastatin/analogs & derivatives , Lovastatin/pharmacology , Osteogenesis/drug effects , Stem Cells/metabolism , Transforming Growth Factor beta , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Animals , Antigens, Differentiation/biosynthesis , Antigens, Differentiation/genetics , Ascorbic Acid/pharmacology , Bone Morphogenetic Protein 2 , Cells, Cultured , Glycerophosphates/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Mice , Osteoblasts/cytology , Osteoblasts/metabolism , Osteocalcin/biosynthesis , Osteocalcin/genetics , Osteopontin , RNA, Messenger/metabolism , Sialoglycoproteins/biosynthesis , Sialoglycoproteins/genetics , Stem Cells/cytology , Stem Cells/drug effects , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...